Oral antiplatelet therapies have no effect on circulating levels of RANTES in patients with coronary artery disease.
Bahrmann
P
P
Klinik für Innere Medizin III (Kardiologie, Angiologie, Internistische Intensivmedizin), Friedrich-Schiller-Universität, Jena, Germany. philipp.bahrmann@med.uni-jena.de
Sigusch
H H
HH
Surber
R
R
Figulla
H R
HR
D000368:Aged; D000789:Angina, Unstable / Q000097:blood / Q000503:physiopathology; D018946:Chemokine CCL5 / Q000097:blood*; D018925:Chemokines / Q000097:blood; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000097:blood* / Q000503:physiopathology; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000150:complications / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000494:pharmacology
D018946:Chemokine CCL5; D018925:Chemokines; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine